SEL-403

N/A

Report date: 2026/03/04 16:35:28

Base Information

Drug NameSEL-403
Drug Alias NameSEL-403
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunosuppressantsMesothelin inhibitorsMethylmalonyl-CoA Mutase stimulants +[4] 
TargetsMesothelinMethylmalonyl-CoA MutaseSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes LMB-100SEL 110
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsMesothelioma

Other Information

ATC CodeN/A
Related LinksN/A